Ozempic and Mounjaro, approved for diabetes, are covered when prescribed for diabetes even if weight loss occurs as a secondary benefit
Newer studies cite even more benefits of these medications, reducing obesity-related disorders like sleep apnea and other metabolic dysfunctions
Insulin resistance is a condition in which the bodys cells become less responsive to the effects of insulin, leading to elevated blood sugar levels
For patients who need ongoing support but can't commit to monthly injections indefinitely, this flexibility matters
This is why it is so important to start our free weight loss assessment to ensure you are always receiving the correct, high-quality dosage through our partner FDA-registered pharmacies
The experimental trail included a 26-week treatment period, a dose-escalation period of up to 6 weeks, and a 6-week follow-up period after the end of treatment